Patients Stopping Slimming Jabs Regain Pounds at a Quadrupled Rate Compared to Those on Conventional Diets

Illustration of pharmaceutical injection and scale
Obesity treatment involves long-term strategies.

New research indicates that individuals who stop using blockbuster weight-loss injections like semaglutide or tirzepatide tend to recover reduced body mass much more quickly than those who halt conventional lifestyle plans.

Research printed in a major health publication shows that while overweight people can lose about a fifth of their total mass while on the medication, the weight returns at an estimated rate of nearly a kilo each month after stopping.

"Users purchasing these medications should be informed of the potential of quick rebound weight gain when the treatment is stopped," cautioned lead investigator Dr. Susan Jebb.

This pace of regain implies a return to pre-treatment mass within about a year and a half.

Weighing Treatments

The research, which examined 37 of trials involving thousands of participants, compared the outcomes of these new drugs with other pills.

Scientists emphasize that individuals who lose weight through lifestyle changes alone usually experience a slower creep back—around 0.1 kg a month—after stopping.

Understanding the Quick Rebound

Nutrition scientists believe the mechanism of the drugs accounts for the amplified weight return.

The injections imitate a natural hormone called GLP-1, which helps regulate hunger.

"Sustained high doses of GLP-1 concentrations several times higher than normal could lead to the system to generate a reduced amount of its own natural GLP-1, and may also diminish sensitivity to its actions," explained Dr. Adam Collins, a nutrition specialist.

"Stopping of this GLP-1 'fix' means appetite is uncontrolled, making binge eating much more probable."

A Chronic Issue?

Medical guidelines advise the jabs for people with obesity-related health risks, alongside recommended diet and exercise modifications.

Many experts argue that, given the significant potential of weight regain, the therapy might need to be long-term.

This perspective is reinforced by pharmaceutical companies, who note that the results "highlight the persistent character of excess weight," comparing it to managing conditions like high blood pressure.

Patient Testimonies

People who have come off the jabs describe a intense return of hunger.

"It felt as if a switch that goes on and you're instantly ravenous," described an individual.

The struggle is worsened if individuals have not adopted permanent dietary or behavioural changes during treatment.

Significant Use

Survey data show that millions of adults in the UK have tried these injections in the past year, with interest remaining high.

  • Use is greater among females than males.
  • The 40s and 50s age group shows the highest usage rates.
  • A large proportion obtain the medications through private prescriptions rather than public health services.

In conclusion, experts stress that while these medications are potent tools for shedding pounds, they are not a magic cure and long-term success hinges on ongoing behavioural support.

Anne Roberts
Anne Roberts

A tech enthusiast and lifestyle writer with a passion for exploring how innovation shapes everyday experiences.